Hidradenitis Suppurativa Among Patients with Human Immunodeficiency Virus: Investigating Patient and Disease Characteristics, and Misdiagnosis

COMMENTED

Acne

Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa

JAMA Dermatol.

Reddy S, Strunk A, Garg A

doi: 10.1001/jamadermatol.

Melanoma and Skin CancerImmunodeficiency

Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load

JAMA Dermatol.

Asgari MM, Ray GT, Quesenberry CP Jr, Katz KA, Silverberg MJ

doi: 10.1001/

Acne

High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors

J Eur Acad Dermatol Venereol.

Durán-Vian C, Arias-Loste MT, Hernández JL, Fernández V, González M, Iruzubieta P, Rasines L, González-Vela C, Vaqué JP, Blanco R, Crespo J, González-López MA

doi: 10.1111/jdv.15764.

Acne

Risk of connective tissue disease, morphea and systemic vasculitis in patients with hidradenitis suppurativa

J Eur Acad Dermatol Venereol.

Schneeweiss MC, Merola JF, Schneeweiss S, Wyss R, Rosmarin D

doi: 10.1111/jdv.16728.

Acne

Incidence of Long-term Opioid Use Among Opioid-Naive Patients With Hidradenitis Suppurativa in the United States

JAMA Dermatol.

Reddy S, Orenstein LAV, Strunk A, Garg A

doi: 10.1001/jamadermatol.2019.2610.

Immunodeficiency

Diagnostic Interpretation of Genetic Studies in Patients with Primary Immunodeficiency Diseases: A Working Group Report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma, and Immunology

J Allergy Clin Immunol.

Chinn IK, Chan A, Chen K, Chou J, Dorsey MJ, Hajjar J, Jongco AM 3rd, Keller MD, Kobrynski LJ, Kumanovics A, Lawrence MG, Leiding JW, Lugar PL, Orange JS, Patel K, Platt CD, Puck JM, Raje N, Romberg ND, Slack MA, Sullivan KE, Tarrant TK, Torgerson TR, Walter JE

doi: 10.1016/j.jaci.2019.09.009.

Immunodeficiency

Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study

Eur J Pharm Sci.

Melamed IR, Borte M, Trawnicek L, Kobayashi AL, Kobayashi RH, Knutsen A, Gupta S, Smits W, Pituch-Noworolska A, Strach M, Pulka G, Ochs HD, Moy JN

doi: 10.1016/j.ejps.2018.03.007.

Acne

Disease Trajectories for Hidradenitis Suppurativa in the Danish Population

JAMA Dermatol.

Kjærsgaard Andersen R, Jørgensen IF, Reguant R, Jemec GBE, Brunak S

doi: 10.1001/jamadermatol.

Acne

Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum

JAMA Dermatol.

Lyons AB, Peacock A, McKenzie SA, Jacobsen G, Naik HB, Shi VY, Hamzavi IH, Hsiao JL

doi: 10.1001/jamadermatol.2020.0777.

Related content

Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa

Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load

High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors

Risk of connective tissue disease, morphea and systemic vasculitis in patients with hidradenitis suppurativa

Incidence of Long-term Opioid Use Among Opioid-Naive Patients With Hidradenitis Suppurativa in the United States

Diagnostic Interpretation of Genetic Studies in Patients with Primary Immunodeficiency Diseases: A Working Group Report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma, and Immunology

Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study

Disease Trajectories for Hidradenitis Suppurativa in the Danish Population

Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum